Beobachtungsplan, NIS 677: Health Care Professional survey on understanding of key risk minimisation measures related to interstitial lung disease (ILD) / pneumonitis with Trastuzumab Deruxtecan treatment

Datei

• Artikel "Beobachtungsplan, NIS 677: Health Care Professional survey on understanding of key risk minimisation measures related to interstitial lung disease (ILD) / pneumonitis with Trastuzumab Deruxtecan treatment"Herunterladen(PDF, 463KB, Datei ist nicht barrierefrei)